EHSG-KF clinical trials

A Phase IIb, prospective, intra-patient randomised controlled, multicentre study to evaluate the safety and efficacy of an autologous bio-engineered dermo-epidermal skin substitute (EHSG-KF) for the treatment of partial deep dermal and full thickness burns in adults and adolescents in comparison to autologous split-thickness skin grafts (STSG) (BA)

This study is testing a new type of skin graft made from a patient's own cells for severe burns. It compares this new graft to standard skin grafting to see if it heals better and is safe for adults and teenagers.